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Despite extensive clinical  and descriptive studies of the human  C-reactive 
protein and definition of the experimental model, the rabbit Cx-reactive protein, 
nothing is known about the site or sites of origin of these acute phase proteins 
(1). It has been postulated that they appear as the direct result of tissue damage, 
but no evidence has been advanced to support this hypothesis. Earlier studies 
of the C-reactive protein and of the Cx-reactive protein related to their possible 
function or functions, but no studies indicating a possible cellular  origin of the 
acute phase proteins have been reported (2, 3). 
The present work is concerned with an investigation  of the reticulo-endo- 
thelial system as the probable cellular system responsible for elaboration of the 
Cx-reactive protein. The investigation stems from the observation reported in 
the preceding study that the characteristic  inflammatory response caused in 
rabbits by the intracutaneous injection of Cx-reactive protein incorporated in 
adjuvant  can be prevented  by previous intravenous  administration  of large 
amounts  of thorotrast,  a  substance commonly used to  "block" the reticulo- 
endothelial system (4). In earlier unpublished experiments done in this labora- 
tory it was found that intravenously  administered India ink and trypan blue 
dye, agents used to  "block" the reticulo-endothelial  system, caused the  ap- 
pearance  of  Cx-reactive  protein  in  the  blood of  rabbits.  Intravenously  ad- 
ministered thorotrast  proved to have this same property.  It was found that 
thorotrast caused the appearance of Cx-reactive protein in the blood, but that 
repeated injections caused successively decreasing responses until finally further 
intravenous injections caused the appearance of little or no further Cx-reactive 
protein in the blood. 
The goal of complete blockade of the reticulo-endothelial  system cannot be 
readily achieved for several reasons: First, not all of the fixed elements of the 
system in various organs can be reached by intravenously administered "block- 
ing agents,"  and although  this unattainable  portion represents only a  minor 
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part  of  the  reticulo-endothelial system,  it  may still remain functioning (5). 
Secondly, new elements may be formed after blocking agents have been taken 
up and fixed by the available cells.  Moreover,  the  elements of  the reticulo- 
endothelial  system  which  are  not  reached by  intravenously  administered 
blocking agents remain active. 
Materials and Methods 
Two types of  experiments were  carried  out in the  course of  this  study. In the 
first set of experiments thorotrast was given intravenously to determine its effect on 
the production of the Cx-reactive protein. In the second set of experiments rabbits 
which had received large amounts of intravenous thorotrast,  amounts sufficient to 
"block"  the  reticulo-endothelial system, were  challenged with  Cx-reactive protein 
incorporated in adjuvant and with dermal infection with pneumococcus Type I. 
Preparation of Cx-Reactive Protein for Incorporation in Adjuvant  and Preparation 
of Adjuvant were carried out as in the preceding study (4). 
Preparation of Sheep Antiserum  to  Cx-Reactive Protein and  the Precipitin  Tests 
with Rabbit Serum Employing Sheep Antiserum were  carried out as in the preceding 
study. 
Experimental Animals.--Rabbits weighing between 2500 and 3500 gm. were used in all 
experiments. A control bleeding was done on each animal to insure the absence of Cx-reactive 
protein in the serum at the beginning of each experiment. 
Thorotrast.--Thorotrast, a 24 per cent to 26 per cent colloidal thorium dioxide in 25 per 
cent aqueous dextrin, was used in all experiments.  1 This substance has a direct toxic effect 
on rabbits,  and the LDso varies from batch to batch.  Very high doses of thorotrast  were 
required to load the reticulo-endothellal system to an effective point. Thorotrast  was given 
intravenously  to sixteen rabbits.  Eight rabbits received 41 cc. intravenously in four 9 cc. 
doses with a final dose of 5 cc.; the first three injections were given at intervals of 120 hours, 
the last two at intervals of 72 hours. Two of these eight rabbits died within 12 hours after 
the first injections; the remaining six tolerated the consecutive doses of thorotrast  and none 
of them appeared ill during the course of the experiments. 
An attempt to obtain an acute  blockade of the reticulo-endothellai system by giving a 
first dose of 9 cc. and consecutive injections of 12 cc. every 12 hours failed and all eight of 
the rabbits died within 36 hours following the first injection. 
RESULTS 
Findings  with  Thorolrast-Treated  Rabbits.--The  findings in  rabbits  given 
serial injections of thorotrast are presented here. 
All of the rabbits had previously been given 1 cc. of Cx-reactive protein in adjuvant 
intracutaneously to obtain control data. The first injection of thorotrast was given 
after Cx-reactive protein had been absent from the blood for  3 days. Following the 
injection of thorotrast Cx-reactive protein appeared in the blood in detectable amounts 
as early as 8 hours in all rabbits. This is the earliest consistent time at which the 
Cx-reactive protein has been observed to appear in response to any stimulus used in 
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this laboratory. The amount of Cx-reactive protein in the blood increased  progres- 
sively to  reach  maximum values  between  the  28th  and  32nd  hour  after  the  first 
injection of thorotrast and then decreased  rapidly to become negative between the 
72nd  and 96th hours.  The successive  injections  of thorotrast resulted in decreasing 
Cx-reactive protein responses  until finally  the  last injection  elicited  little or no re- 
sponse.  This phenomenon is illustrated in Fig.  1 where  the precipitin reactions ob- 
tained between antiserum to Cx-reactive protein and sera from successive bleedings 
on three rabbits following three serial intravenous injections  of thorotrast are shown. 
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F1o. I. The precipifin  reactions  obtained  between antiserum to Cx-reactive protein and 
sera  from successive  bleedings on three  rabbits  following  three  scrim injections  of thorotrast. 
TABLE I 
Maximal Antigen-Antibody Precipitin Reactions for  Cx-Reactive Protein (Measured in 
Millimeters) Following  Successive Injections of Thorotrast 
Rabbit  No  ..... 
First injection 
Second injection 
rlfird injection 
Fourth injection 
Fifth injection 
2  3 
24  5 
15  5 
13  4 
4  3 
3 
24 
8 
6 
5 
4 
5  6 
8  12 
6  10 
5  9 
5  Tr 
2  Tr 
The maximal antigen antibody precipitin readings obtained with sera from 
six rabbits following each of  five successive injections  of thorotrast  are  pre- 
sented  in Table I. 
This pattern of decreasing Cx-reactive protein response may be the expres- 
sion of a progressive loading of the reticulo-endothelial system, since it has been 
shown that the greater the stimulating action of a blocking agent on the reticulo- 
endothelial  system immediately following its administration,  the higher is its 
capacity to block the system (6). 
Findings  with Injection  of  Cx-Reactive  Protein  in  Adjuvant  in  Thorotrast- 
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endothelial system was thought to be almost completely blocked and rabbits 
were challenged with  two different  stimuli to the production  of Cx-reactive 
protein,  (a)  Cx-reactive  protein  incorporated  in  adjuvant  and,  (b)  dermal 
infection with pneumococcus  Type I.  Experiments reported  in the preceding 
study showed that intracutaneous injection of Cx-reactive protein in adjuvant 
is followed by typical cutaneous inflammatory lesions in the recipient rabbits, 
and by the appearance of large amounts of Cx-reactive protein in the blood (4). 
Three  rabbits  whose  reticulo-endothelial  systems were  loaded  with  thorotrast 
each received  1 cc.  of Cx-reactive protein  in  adjuvant  intracutaneously  72  hours 
following the final injection  of thorotrast. The results obtained were compared with 
those obtained with  the same rabbits following  a  similar injection  administered  7 
days before the first injection  of thorotrast was given. Following the second injection 
of Cx-reactive protein in adjuvant marked differences were noted in all three animals 
both in the cutaneous response and in the blood Cx-reactive protein response.  None 
of the "blocked" rabbits developed the typical inflammatory lesion seen in the con- 
trol experiment. The nodules produced by the second injection of Cx-reactive protein 
in adjuvant did not change in size following injection  and at 24 hours their diameters 
had not increased.  Only a very slight inflammatory change occurred,  consisting  of a 
faint  erythematous halo about  the  site  of injection;  one  of the  rabbits  exhibited 
no erythema whatever. 
In response to this second injection  of Cx-reactive protein in adjuvant all of the 
rabbits produced a much smaller amount of Cx-reactive protein than in the control 
experiment and it was detectable in the blood for a shorter period of time. The maxi- 
mal precipitin readings  for Cx-reactive protein in the sera of these rabbits following 
the second  Cx-reactive protein in adjuvant injection  as compared with the maximal 
readings  obtained in  the control experiment were  reduced by 78 per cent  in  that 
rabbit which gave a trace amount of Cx-reactive protein following the last injection 
of thorotrast and by 52.9 per cent and S0 per cent in the other two rabbits. 
Findings with Pneumococcal Infection oj the Skin in Thorotrast-T~eated Rab- 
bits.--Rabbits are known to respond to experimental pneumococcal infection 
of the skin by producing large amounts of Cx-reactive protein (1). 
In  this  experiment  three  normal  control  rabbits  and  three  thorotrast-treated 
rabbits were injected intracutaneously with 0.15 co. of an undiluted  12 hour blood 
broth culture  of  pneumococcus,  Type I, strain  SV1. Within  18 hours Cx-reactive 
protein was detectable in the blood of both the control and the experimental animals. 
It increased sharply in amount in the control animals to reach its highest value in the 
32nd  to 36th hour following infection.  At the site of injection  an area of erythema 
developed which  at its height  (36  to 48  hours)  covered an area of approximately 
6x9 cm. 
The three  rabbits which  had previously been treated  with 41  ml.  of thorotrast 
exhibited a striking difference in their response to dermal infection with pneumococcus 
as  compared with  the  control  group.  This  difference  was  particularly  notable  in 
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to produce Cx-reactive protein following  the final  injection of thorotrast produced 
very small  amounts  of  the  substance  in  response  to  the  pneumococcal infection. 
The remaining two rabbits produced relatively small amounts of Cx-reacfive pro- 
tein.  Comparison of the Cx-reactive protein responses  of these two groups of three 
rabbits, the control group and the thorotrast-treated group, are shown  in  Figure 2. 
At the injection sites the area of erythema was definitely  less marked in the thoro- 
trast-treated rabbits than in the control animals, covering an area of approximately 
five times five cms. as compared with six by nine cms. in the control group. One of 
the  thorotrast-treated  rabbits  had  only  a  faint  erythematous area  three  cms.  in 
diameter. 
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FIo. 2.  Comparison of the Cx-reacfive protein responses of two groups of three rabbits 
infected dermally with pneumococcus Type I. The animals in group a were normal, untreated 
rabbits. Those in group b had received successive injections of thorotrast. 
DISCUSSION 
The  data  obtained  in  this  study  suggest  that  blockade  of  the  reticulo- 
endothelial system may markedly inhibit the production of Cx-reactive protein. 
The production of relatively small amounts of this substance after the adminis- 
tration of large amounts of thorotrast may be explained by the residual func- 
tioning elements of the reticulo-endothelial system which had not been reached 
by the blocking agent. Following the administration of Cx-reactive protein in 
adjuvant,  thorotrast-treated  rabbits  responded  with  the  production  of  less 
circulating  Cx-reactive protein  than  did  the  control  animals.  More  marked 
differences were noted when a more potent stimulus such as dermal infection 
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injections almost completely inhibited the production of Cx-reactive protein. 
It  is probable  that  this inhibition was  caused by blockade of the  reticulo- 
endothelial system, but a  direct toxic effect of thorotrast on cells other than 
those of the reticulo-endothelial system cannot be ruled out. 
These experiments further suggest that Cx-reactive protein may be involved 
in the mechanism of local inflammatory lesions,  since inflammation at the site 
of injection of Cx-reactive protein in adjuvant was reduced when Cx-reactive 
protein  production  was  inhibited  following successive  thorotrast  injections. 
Further  experiments  on  a  possible  protective  effect of  injected  Cx-reactive 
protein on rabbits subjected to chemical injury and to experimental infection 
are indicated. The inhibition of endogenous Cx-reactive protein production by 
thorotrast provides a method which renders such experiments possible. 
SUMMARY 
It has been found that normal rabbits respond to the intravenous administra- 
tion of thorotrast by producing Cx-reactive protein. The amount of Cx-reactive 
protein produced in response to successive injections of thorotrast progressively 
diminishes until finally little or no further Cx-reactive protein production can 
be elicited. The reticulo-endothelial system is believed to be effectively  blocked 
at this point. When such "blocked" rabbits are injected intracutaneously with 
Cx-reactive protein incorporated in adjuvant they produce significantly less 
Cx-reactive protein than the amounts elicited by the same stimulus prior to 
thorotrast treatment. They also fail to develop the characteristic inflammatory 
reaction seen in the control experiments. In addition, rabbits whose reticulo- 
endothelial systems are loaded with thorotrast respond to dermal infection with 
Type I  pneumococcus by producing only very small amounts of Cx-reactive 
protein in comparison with the control animals. 
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